3-D Echo Workshop at Echo 2016

ttend the Wednesday afternoon workshop and you will receive a time-limited, fully functional, up-loadable version of QLAB as well as important TEE and TTE volumes. Workshop features:

  • WORKSHOP 3DQ: Analysis of Aortic Valve Morphology, 
    Aortic Root Morphology and Function
  • WORKSHOP 3DQ: Analysis of Mitral Valve Morphology and Function
  • WORKSHOP 3DQ: Calculating EF and LV Mass
  • And the opportunity for Q&A
This illustrates how volanesorsen works to prevent the formation of apoC-III protein. Familial chylomicronemia syndrome (FCS) is a rare, genetic disease characterized by mutations in genes affecting the production or functionality of lipoprotein lipase (LPL).
Consistent with previous clinical observations with this drug in non-FCS HTG patients, volanesorsen produced significant, rapid and prolonged reductions in mean fasting plasma apoC-III (-81%) and TG (-69%) levels. Familial chylomicronemia syndrome (FCS) is a rare, genetic disease characterized by mutations in genes affecting the production or functionality of lipoprotein lipase (LPL).
volanesorsen. Familial chylomicronemia syndrome (FCS) is a rare, genetic disease characterized by mutations in genes affecting the production or functionality of lipoprotein lipase (LPL).

Familial chylomicronemia syndrome (FCS) is a rare, genetic disease characterized by mutations in genes affecting the production or functionality of lipoprotein lipase (LPL), an enzyme necessary for the metabolism of triglycerides (TG). People living with FCS can present with severe hypertriglyceridemia (HTG) and an elevated risk of TG-induced pancreatitis. Apolipoprotein C-III (apoC-III), a 79 amino acid glycoprotein that is synthesized principally in the liver, is a key regulator of serum TG.

EP Live

EPLive is a 2 day intensive educational meeting targeting practicing electrophysiologist as well as fellows in training. The meeting consists of four sections: AF ablation, VT ablation, Devices and new technologies. In addition, a panel of recognized experts will provide commentary and discussion.  Previously recorded cases will also be shown.  

Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph Horizon positron emission tomography/computed tomography (PET/CT) system, which offers premium performance at a low total cost of ownership.

Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) has cleared the Magnetom Amira 1.5 Tesla magnetic resonance imaging (MRI) system.

This case study is from the Cardiac Imaging Department, Hospital Clinic, Barcelona, Spain. A woman in her early 60s came to the emergency room with left hemiparesis and her medical history suggested several reasons for concern. She was a sufferer of rheumatic valve disease since childhood and had a history of valve surgeries. They used 3-D echo to clearly identify a small thrombus covering part of the prosthetic ring, which had not been completely clear in the 2-D echo.

GE Healthcare is taking the next leap in image quality performance, quantification and workflow with the introduction of a new generation scanners designed around and built upon GE’s new software-based beamformer platform, cSound. The Vivid S70, Vivid E90 and Vivid E95 systems all are designed around this cSound platform. 

Download the PDF to read more.

On the 100th anniversary of the Endurance expedition to Antarctica led by Sir Ernest Shackleton, doctors writing in the Journal of the Royal Society of Medicine believe the explorer may have had the congenital defect commonly known as a 'hole in the heart'.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now